Boston Bio-Tech Company Cutting 60 Percent of Staff

The Boston Business Journal reports febit Inc., a DNA analysis technology firm, is slashing its Boston-area workforce by 60 percent.

The German-based bio-tech company, founded in 2005, employs between 90 and 100 people at its Lexington center. According to the report, the cuts come as febit shifts its focus to blood-based microRNA biomarker discovery, rather than genomics services.

“We are grateful to febit’s employees who developed the instruments business and successfully ran the genomics services,” Co-CEO Jochen Kohlhaas said in a press release today.

Also as part of the restructuring, CEO Cord Staehler resigned from the company.